Correlation Engine 2.0
Clear Search sequence regions


  • cases (1)
  • coronavirus (2)
  • d dimer (2)
  • heparin (1)
  • humans (1)
  • IL 6 (1)
  • lung (1)
  • patients (4)
  • prognostic (2)
  • research (1)
  • stroke (1)
  • thrombocytopenia (2)
  • thrombosis (4)
  • ticagrelor (1)
  • troponins (1)
  • Sizes of these terms reflect their relevance to your search.

    The novel coronavirus SARS-CoV-2, responsible for the 2019-2020 global (COVID-19) pandemic, is a respiratory virus associated with the development of thromboembolic complications and respiratory failure in severe cases. Increased risk of pulmonary embolism and thrombosis has been identified in COVID-19 patients, alongside accompanying elevations in potential prognostic biomarkers, including D-dimer, IL-6 and cardiac specific troponins. Our aim was to provide a scoping review of the available literature regarding thrombosis risk, other cardiovascular implications, and their biomarkers in COVID-19 to highlight potential disease mechanisms. Authors conducted a literature search in PubMed using MeSH headings "disseminated intravascular coagulation", "pulmonary embolism", "thromb*", "stroke", "myocardial infarction" and "acute lung injury", as well as terms "COVID-19", "SARS-CoV-2", "2019 novel coronavirus" and "2019-nCoV". COVID-19 disease is characterised by the interactions between hyperactive coagulation and complement systems - induced by hyper-inflammatory conditions, resulting in a pro-thrombotic state and diffuse tissue injury. There are several promising prognostic markers of disease severity, with D-dimer the most significant. The presence of thrombocytopenia appears to be a key indicator of patient deterioration. Further research is required to understand the underlying pathophysiology in COVID-19 and its implications in disease progression and patient management. Randomised trials are urgently needed to determine the safety of proposed therapeutic anticoagulation with heparin and the role for anti-platelet agents, such as Ticagrelor, in patient management. Copyright © 2021 Elsevier Ltd. All rights reserved.

    Citation

    Eden M Page, Robert A S Ariëns. Mechanisms of thrombosis and cardiovascular complications in COVID-19. Thrombosis research. 2021 Apr;200:1-8

    Expand section icon Mesh Tags

    Expand section icon Substances


    PMID: 33493983

    View Full Text